However, Schwartz et al. reported that the inhibition of TLR3 signaling using phenyl methimazole (C10) in combination with tamoxifen may increase the effectiveness of the current treatments of breast cancer [20]. The gene discussed is TLR3; the disease is breast carcinoma.